Soluble CD19 CAR Sandwich ELISA Kit for CAR-T Expansion and Persistence Monitoring

The Soluble CD19 CAR Sandwich ELISA Kit quantitatively measures the extracellular domain of CD19-specific CAR shed into human serum, plasma and culture supernatant. It provides a non-invasive readout of CAR-T expansion and persistence for translational research and clinical monitoring.

Order information

Catalog No.Product NameKit SizePrice (In USD)Plate format
GMV-LVc-CD19-ELISA-1Soluble CD19 CAR Sandwich ELISA Kit96T96-well, 12 × 8 removable strips, pre-coated and ready to use

Description

Analyte / TargetSoluble CD19 CAR (CAR ectodomain shed from FMC63-based anti-CD19 scFv CAR)
Species ReactivityHuman
Assay TypeQuantitative sandwich ELISA (capture anti-CAR mAb + biotinylated target antigen)
Detection MethodColorimetric, TMB substrate; absorbance read on a standard microplate reader
Sample TypeHuman serum, plasma (EDTA / heparin) and cell culture supernatant
Kit Components96-well strip plate pre-coated with anti-CAR capture mAb; lyophilized recombinant target-antigen standard; biotinylated target antigen (detection); streptavidin-HRP; sample diluent; concentrated wash buffer; TMB substrate; stop solution; plate sealer
Plate Format96-well, 12 × 8 removable strips, pre-coated and ready to use
Assay WorkflowSingle-day bench workflow: sample / standard incubation, wash, biotinylated antigen, streptavidin-HRP, TMB substrate and stop. Compatible with standard manual and automated microplate washers.
PerformanceA broad quantitative working range is covered by an eight-point standard curve with 4-PL data reduction, and the assay is tuned to the levels of shed CAR typically found in serum, plasma and culture supernatant. Reproducibility within and between runs is carefully controlled, spike recovery in serum, plasma and culture medium is acceptable, and samples behave linearly on dilution, so concentrated samples can be diluted into the working range with confidence. Detailed performance data are documented per lot in the Certificate of Analysis.
SpecificityRecognizes the CD19-binding ectodomain of CD19 CAR; no cross-reactivity with human IgG / Fc, recombinant soluble CD19, or CARs of unrelated specificity (CD20, HER2, BCMA, GPC3).
Storage & StabilityStore at 2–8 °C; the coated plate must not be frozen. Kit reagents are stable until the expiry date printed on the label.
ApplicationQuantification of soluble CD19 CAR in patient serum / plasma for CAR-T PK-PD and persistence monitoring; supernatant CAR expression QC; comparability of CAR constructs.
Products descriptionChimeric antigen receptor (CAR) T-cell therapy against CD19 has become the benchmark of adoptive cell therapy for B-cell malignancies. After infusion, a fraction of the CAR ectodomain is proteolytically shed from the cell surface and circulates as soluble CAR, so its level in peripheral blood tracks CAR-T expansion, contraction and long-term persistence without requiring cell sampling. This kit pairs an anti-CAR capture antibody with a biotinylated CD19 antigen for detection, giving an antigen-binding-competent readout rather than a generic anti-scFv signal. It is intended for pharmacokinetic / pharmacodynamic profiling of CD19 CAR-T products, correlation of soluble CAR with flow-cytometric CAR-T frequencies, and supernatant QC of CAR expression during manufacturing.



<